迈克生物：公司通过高研发筑基、全球化扩圈、智慧化提效，把技术储备转化为竞争力

Core Viewpoint - The company is transitioning from a growth market to a mature market in the in vitro diagnostics sector, focusing on enhancing competitiveness through R&D investment, global expansion, and smart laboratory upgrades [1] Group 1: R&D Investment - The company has invested over 1.4 billion yuan in R&D over the past five years, positioning itself among the industry leaders [1] - Strong R&D capabilities and an expanding technology reserve are fundamental to maintaining core competitive advantages and ensuring future growth [1] Group 2: Global Expansion - The company is actively exploring international markets and has established a global marketing network under the "16+1" strategic deployment [1] - The company is also advancing localized manufacturing to create a second growth curve [1] Group 3: Smart Laboratory Development - The company is committed to integrating new information technologies with diagnostic technologies to upgrade traditional laboratories to smart laboratories [1]